Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microsecond time-resolved X-ray scattering by utilizing MHz repetition rate at second-generation XFELs.

Nature methods·2024
Same author

The <i>pypadf</i> package: computing the pair angle distribution function from fluctuation scattering data.

Journal of applied crystallography·2024
Same author

Crystal structure via fluctuation scattering.

IUCrJ·2024
Same author

Lyotropic liquid crystal phases of monoolein in protic ionic liquids.

The Journal of chemical physics·2024
Same author

3D-printed sheet jet for stable megahertz liquid sample delivery at X-ray free-electron lasers.

IUCrJ·2023
Same author

Observations of phase changes in monoolein during high viscous injection.

Journal of synchrotron radiation·2022
Same journal

Diplomatic roles of regional coordinators for WHO Member States.

Bulletin of the World Health Organization·2026
Same journal

Evaluation of an application for investments in cataract surgery, Ethiopia.

Bulletin of the World Health Organization·2026
Same journal

An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

Bulletin of the World Health Organization·2026
Same journal

Fundamental changes in regulation to improve access to biosimilars.

Bulletin of the World Health Organization·2026
Same journal

A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

Bulletin of the World Health Organization·2026
Same journal

Ebola at a critical juncture: preparedness must outpace transmission.

Bulletin of the World Health Organization·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

Ending polio, one type at a time.

Patrick Adams

    Bulletin of the World Health Organization
    |July 19, 2012
    PubMed
    Summary
    This summary is machine-generated.

    The global polio endgame strategy requires making the inactivated polio vaccine more affordable. This plan is crucial for low- and middle-income countries to achieve polio eradication.

    More Related Videos

    Whole Body Vibration Methods with Survivors of Polio
    04:16

    Whole Body Vibration Methods with Survivors of Polio

    Published on: October 17, 2018

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    Related Experiment Videos

    Last Updated: May 20, 2026

    Particle Agglutination Method for Poliovirus Identification
    07:06

    Particle Agglutination Method for Poliovirus Identification

    Published on: April 20, 2011

    Whole Body Vibration Methods with Survivors of Polio
    04:16

    Whole Body Vibration Methods with Survivors of Polio

    Published on: October 17, 2018

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    Area of Science:

    • Global health
    • Vaccinology
    • Infectious disease control

    Background:

    • The polio endgame strategy necessitates global cooperation and resource allocation.
    • Affordability of the inactivated polio vaccine (IPV) is a key challenge for low- and middle-income countries (LMICs).
    • Current vaccination programs aim for the final stages of polio eradication.

    Discussion:

    • Economic accessibility of IPV is paramount for achieving global polio eradication goals.
    • International partnerships are essential to reduce vaccine costs for LMICs.
    • Sustained political will and funding are critical for the success of the polio endgame.

    Key Insights:

    • A global plan for polio eradication has been endorsed by multiple countries.
    • Making inactivated polio vaccine more affordable is central to this endgame strategy.
    • Focus on LMICs highlights the need for equitable vaccine access.

    Outlook:

    • Successful implementation could lead to the final eradication of poliovirus.
    • Continued investment in vaccine affordability is projected.
    • The strategy emphasizes a sustainable approach to global health security.